Redx Pharma Plc

AIM:REDX Rapporto sulle azioni

Cap. di mercato: UK£58.3m

Redx Pharma Gestione

Gestione criteri di controllo 3/4

Redx Pharma's CEO is Lisa Mary Anson, appointed in Jun 2018, has a tenure of 5.92 years. total yearly compensation is £608.13K, comprised of 94.9% salary and 5.1% bonuses, including company stock and options. directly owns 0.19% of the company’s shares, worth £112.75K. The average tenure of the management team and the board of directors is 3 years and 3 years respectively.

Informazioni chiave

Lisa Mary Anson

Amministratore delegato

UK£608.1k

Compenso totale

Percentuale dello stipendio del CEO94.9%
Mandato del CEO5.9yrs
Proprietà del CEO0.2%
Durata media del management3yrs
Durata media del Consiglio di amministrazione3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Does Redx Pharma (LON:REDX) Have A Healthy Balance Sheet?

Aug 22
Does Redx Pharma (LON:REDX) Have A Healthy Balance Sheet?

Is Redx Pharma (LON:REDX) Using Too Much Debt?

May 22
Is Redx Pharma (LON:REDX) Using Too Much Debt?

Bullish: Analysts Just Made A Significant Upgrade To Their Redx Pharma Plc (LON:REDX) Forecasts

Jul 09
Bullish: Analysts Just Made A Significant Upgrade To Their Redx Pharma Plc (LON:REDX) Forecasts

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Lisa Mary Anson rispetto agli utili di Redx Pharma?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2023UK£608kUK£577k

-UK£33m

Jun 30 2023n/an/a

-UK£31m

Mar 31 2023n/an/a

-UK£29m

Dec 31 2022n/an/a

-UK£24m

Sep 30 2022UK£637kUK£606k

-UK£18m

Jun 30 2022n/an/a

-UK£18m

Mar 31 2022n/an/a

-UK£19m

Dec 31 2021n/an/a

-UK£20m

Sep 30 2021UK£2mUK£615k

-UK£22m

Jun 30 2021n/an/a

-UK£20m

Mar 31 2021n/an/a

-UK£18m

Dec 31 2020n/an/a

-UK£14m

Sep 30 2020UK£619kUK£481k

-UK£9m

Jun 30 2020n/an/a

-UK£8m

Mar 31 2020n/an/a

-UK£6m

Dec 31 2019n/an/a

-UK£5m

Sep 30 2019UK£439kUK£390k

-UK£4m

Jun 30 2019n/an/a

-UK£5m

Mar 31 2019n/an/a

-UK£7m

Dec 31 2018n/an/a

-UK£8m

Sep 30 2018UK£372kUK£100k

-UK£9m

Compensazione vs Mercato: Lisa Mary's total compensation ($USD759.28K) is above average for companies of similar size in the UK market ($USD344.28K).

Compensazione vs guadagni: Lisa Mary's compensation has been consistent with company performance over the past year.


AMMINISTRATORE DELEGATO

Lisa Mary Anson (55 yo)

5.9yrs

Mandato

UK£608,127

Compensazione

Mrs. Lisa Mary Whewell Anson serves as the Chief Executive Officer and Executive Director at Redx Pharma PLC since June 1, 2018. She has been President of AstraZeneca UK since 2012 and brings significant l...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Lisa Mary Anson
CEO & Executive Director5.9yrsUK£608.13k0.19%
£ 112.8k
Peter Collum
Chief Financial Officer3yrsNessun datoNessun dato
James Mead
Chief Operating Officer3yrsUK£210.91kNessun dato
Richard Armer
Chief Scientific Officer10.3yrsNessun datoNessun dato
Karl Hard
Head of Investor Relationsno dataNessun datoNessun dato
Claire Solk
General Counsel & Company Secretary2.3yrsNessun datoNessun dato
Caitlin Pearson
Head of Communications2.1yrsNessun datoNessun dato
Cliff Jones
Senior Vice President of Chemistry8.3yrsNessun datoNessun dato
Caroline Phillips
Senior Vice President of Biologyno dataNessun datoNessun dato
Craig Tilston
Head of Development Operationsno dataNessun datoNessun dato
Helen McKeever
Head of Nonclinical Development3.3yrsNessun datoNessun dato
Helen Timmis
Interim Chief Medical Officerless than a yearNessun datoNessun dato

3.0yrs

Durata media

55yo

Età media

Gestione esperta: REDX's management team is considered experienced (3 years average tenure).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Lisa Mary Anson
CEO & Executive Director5.9yrsUK£608.13k0.19%
£ 112.8k
Peter Presland
Independent Non-Executive Director6.5yrsUK£48.75k0.038%
£ 21.9k
Joseph Anderson
Non-Executive Directorless than a yearNessun datoNessun dato
Bernhard Kirschbaum
Independent Non-Executive Director8.3yrsUK£49.00kNessun dato
Jane Griffiths
Independent Non-Executive Chair2.4yrsUK£85.00k0.022%
£ 12.7k
Robert Andrew Scott
Independent Non-Executive Director2.3yrsUK£41.50kNessun dato
Natalie Berner
Shareholder Representative Non-Executive Director3yrsNessun datoNessun dato

3.0yrs

Durata media

65yo

Età media

Consiglio di amministrazione esperto: REDX's board of directors are considered experienced (3 years average tenure).